Repositioning Candidate Details
| Candidate ID: | R0379 |
| Source ID: | DB01364 |
| Source Type: | approved |
| Compound Type: | small molecule |
| Compound Name: | Ephedrine |
| Synonyms: | |
| Molecular Formula: | C10H15NO |
| SMILES: | CN[C@@H](C)[C@H](O)C1=CC=CC=C1 |
| Structure: |
|
| DrugBank Description: | An alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine. It has been used in the treatment of several disorders including asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. It has become less extensively used with the advent of more selective agonists. |
| CAS Number: | 299-42-3 |
| Molecular Weight: | 165.2322 |
| DrugBank Indication: | Ephedrine commonly used as a stimulant, appetite suppressant, concentration aid, decongestant, and to treat hypotension associated with anaesthesia. |
| DrugBank Pharmacology: | Ephedrine is similar in structure to the derivatives amphetamine and methamphetamine. Chemically, it is an alkaloid derived from various plants in the genus Ephedra (family Ephedraceae). Its principal mechanism of action is based upon enhancing the action of norepinephrine at adrenergic receptors. |
| DrugBank MoA: | Ephedrine is a sympathomimetic amine - that is, its principal mechanism of action relies on its direct and indirect actions on the adrenergic receptor system, which is part of the sympathetic nervous system. Ephedrine increases post-synaptic noradrenergic receptor activity by (weakly) directly activating post-synaptic α-receptors and β-receptors, but the bulk of its effect comes from the pre-synaptic neuron being unable to distinguish between real adrenaline or noradrenaline from ephedrine. The ephedrine, mixed with noradrenaline, is transported through the noradrenaline reuptake complex and packaged (along with real noradrenaline) into vesicles that reside at the terminal button of a nerve cell. Ephedrine's action as an agonist at most major noradrenaline receptors and its ability to increase the release of both dopamine and to a lesser extent, serotonin by the same mechanism is presumed to have a major role in its mechanism of action. |
| Targets: | Alpha-1A adrenergic receptor; Beta-1 adrenergic receptor; Beta-2 adrenergic receptor; Sodium-dependent noradrenaline transporter |
| Inclusion Criteria: |
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Diseases ID | DO ID | Disease Name | Definition | Class |
|---|